Cargando…

Human papillomavirus type 16 infection activates the host serine arginine protein kinase 1 (SRPK1) – splicing factor axis

The infectious life cycle of human papillomaviruses (HPVs) is tightly linked to keratinocyte differentiation. Evidence suggests a sophisticated interplay between host gene regulation and virus replication. Alternative splicing is an essential process for host and viral gene expression, and is genera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mole, Sarah, Faizo, Arwa Ali A., Hernandez-Lopez, Hegel, Griffiths, Megan, Stevenson, Andrew, Roberts, Sally, Graham, Sheila V
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Microbiology Society 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414453/ https://www.ncbi.nlm.nih.gov/pubmed/32182205 http://dx.doi.org/10.1099/jgv.0.001402

Ejemplares similares

Control of human papillomavirus gene expression by alternative splicing
por: Graham, Sheila V., et al.
Publicado: (2017)

Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions
por: Xu, Xiaotao, et al.
Publicado: (2017)

Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis
por: Duggan, William P., et al.
Publicado: (2022)

Impaired expression of serine/arginine protein kinase 2 (SRPK2) affects melanoma progression
por: Caetano, Mônica Maria Magalhães, et al.
Publicado: (2022)

SERINE ARGININE PROTEIN KINASE-1 (SRPK1) INHIBITION AS A POTENTIAL NOVEL TARGETED THERAPEUTIC STRATEGY IN PROSTATE CANCER
por: Mavrou, Athina, et al.
Publicado: (2014)

Serine-arginine protein kinase 1 (SRPK1), a determinant of angiogenesis, is upregulated in prostate cancer and correlates with disease stage and invasion
por: Bullock, Nicholas, et al.
Publicado: (2016)

Serine–Arginine Protein Kinase SRPK2 Modulates the Assembly of the Active Zone Scaffolding Protein CAST1/ERC2
por: Arancibia, Duxan, et al.
Publicado: (2019)

Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives
por: Nikas, Ilias P., et al.
Publicado: (2019)

Increased expression of SRPK1 (serine/arginine-rich protein-specific kinase 1) is associated with progression and unfavorable prognosis in cervical squamous cell carcinoma
por: Dong, Zhanfei, et al.
Publicado: (2022)

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma
por: Gout, Stephanie, et al.
Publicado: (2012)

The many faces of SRPK1
por: Bullock, Nicholas, et al.
Publicado: (2017)

Towards understandings of serine/arginine-rich splicing factors
por: Li, Dianyang, et al.
Publicado: (2023)

Serine/arginine-rich splicing factors: the bridge linking alternative splicing and cancer
por: Zheng, Xiang, et al.
Publicado: (2020)

SRPK1 acetylation modulates alternative splicing to regulate cisplatin resistance in breast cancer cells
por: Wang, Cheng, et al.
Publicado: (2020)

FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells
por: Jia, Tao, et al.
Publicado: (2021)

Identification of heterogenous nuclear ribonucleoproteins (hnRNPs) and serine- and arginine-rich (SR) proteins that induce human papillomavirus type 16 late gene expression and alter L1 mRNA splicing
por: Hao, Chengyu, et al.
Publicado: (2021)

Serine and arginine rich splicing factor 1: a potential target for neuroprotection and other diseases
por: Sandoval-Castellanos, Ana M., et al.
Publicado: (2022)

Phosphorylation of SRSF1 by SRPK1 regulates alternative splicing of tumor-related Rac1b in colorectal cells
por: Gonçalves, Vânia, et al.
Publicado: (2014)

Splicosomal and serine and arginine-rich splicing factors as targets for TGF-β
por: Hallgren, Oskar, et al.
Publicado: (2012)

Data on the expression of SRPK1a in mammals
por: Vlassi, Metaxia, et al.
Publicado: (2019)

Serine-arginine protein kinase 1 (SRPK1) promotes EGFR-TKI resistance by enhancing GSK3β Ser9 autophosphorylation independent of its kinase activity in non-small-cell lung cancer
por: Huang, Jing-Qiang, et al.
Publicado: (2023)

Identification of a novel and potent small molecule inhibitor of SRPK1: mechanism of dual inhibition of SRPK1 for the inhibition of cancer progression
por: Chandra, Anshuman, et al.
Publicado: (2020)

Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms’ Tumor Suppressor Wt1
por: Wagner, Kay-Dietrich, et al.
Publicado: (2019)

Elevated SRPK1 lessens apoptosis in breast cancer cells through RBM4-regulated splicing events
por: Lin, Jung-Chun, et al.
Publicado: (2014)

An IGF-1R-mTORC1-SRPK2 signaling Axis contributes to FASN regulation in breast cancer
por: McClellan, Bryan, et al.
Publicado: (2022)

SRPK1 inhibition in prostate cancer: A novel anti-angiogenic treatment through modulation of VEGF alternative splicing
por: Mavrou, Athina, et al.
Publicado: (2016)

Serine/arginine-rich splicing factors belong to a class of intrinsically disordered proteins
por: Haynes, Chad, et al.
Publicado: (2006)

Physiological and Pathological Function of Serine/Arginine-Rich Splicing Factor 4 and Related Diseases
por: Tan, Wanyan, et al.
Publicado: (2018)

Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3ζ in Human T Cells
por: Moulton, Vaishali R., et al.
Publicado: (2015)

Diagnostic Utility of the Immunohistochemical Expression of Serine and Arginine Rich Splicing Factor 1 (SRSF1) in the Differential Diagnosis of Adult Gliomas
por: Broggi, Giuseppe, et al.
Publicado: (2021)

Paraquat Modulates Alternative Pre-mRNA Splicing by Modifying the Intracellular Distribution of SRPK2
por: Vivarelli, Silvia, et al.
Publicado: (2013)

SRPK1/2 and PP1α exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma
por: Liu, Hongda, et al.
Publicado: (2021)

Phosphorylation of serine/arginine‐rich splicing factor 1 at tyrosine 19 promotes cell proliferation in pediatric acute lymphoblastic leukemia
por: Xu, Liting, et al.
Publicado: (2018)

Recruiting a Silent Partner for Activation of the Protein Kinase SRPK1
por: Aubol, Brandon E., et al.
Publicado: (2014)

A serine–arginine-rich (SR) splicing factor modulates alternative splicing of over a thousand genes in Toxoplasma gondii
por: Yeoh, Lee M., et al.
Publicado: (2015)

Myelodysplasia-associated mutations in serine/arginine-rich splicing factor SRSF2 lead to alternative splicing of CDC25C
por: Skrdlant, Lindsey, et al.
Publicado: (2016)

The Rice Serine/Arginine Splicing Factor RS33 Regulates Pre-mRNA Splicing during Abiotic Stress Responses
por: Butt, Haroon, et al.
Publicado: (2022)

Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3
por: Wei, Ziqing, et al.
Publicado: (2023)

Inhibition of SRPK1, a key splicing regulator, exhibits antitumor and chemotherapeutic-sensitizing effects on extranodal NK/T-cell lymphoma cells
por: He, Cuiying, et al.
Publicado: (2022)

Immunohistochemical Expression of Serine and Arginine-Rich Splicing Factor 1 (SRSF1) in Fluoro-Edenite-Induced Malignant Mesothelioma: A Preliminary Study
por: Broggi, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ungmotc58c7bo70542t9j3fqhd